PA007513.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: B20-4.1.1.1), Mouse IgG2a Kappa
The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: B20-4.1.1.1) specifically binds to mouse VEGF.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.PA007394.r2a: In vivo Grade Recombinant Anti-mouse CD115 Monoclonal Antibody, Rat IgG2a Kappa (Clone: AFS98)
The in vivo grade recombinant anti-mouse CD115 rat IgG2a monoclonal antibody was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant rat monoclonal antibody (clone: AFS98) specifically binds to mouse CD115.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse CD115 protein.BP000123-CYT-140: Recombinant Canine Tumor Necrosis Factor-Alpha (TNFα) Protein
Source: E. coli-derived.
The Specific Activity is >3.3?05 IU/mg as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000123-C082: Recombinant Rabbit Tumor Necrosis Factor alpha (TNFα) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000123-CYT-384: Recombinant Human Tumor Necrosis Factor α Mutant
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is < 0.05 ng/ml, corresponding to a Specific Activity of 20,000,000 units/mg.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000123-C036: Recombinant Human Tumor Necrosis Factor-alpha (TNFα) Mutant Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 0.01 ng/ml. Specific Activity of 1.0 x 10^8 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP002214-PRO-005: Recombinant Human TNFAIP3 Interacting Protein 1 (TNIP1) protein
Source: E. coli-derived.
Purity: > 75.0% as determined by SDS-PAGE.BP001950-CA70: Recombinant Human Ephrin A1 (EFNA1) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000123-C008: Recombinant Human Tumor Necrosis Factor α (TNFα) Protein
Source: E. coli-derived.
The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is less than 0.03 ng/ml. Specific Activity of 3.0 x 10^7 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP002287-PRO-694: Recombinant Human Pentraxin-3 (PTX3) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.